# Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients

> **NCT07643727** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 49 (estimated)

## Conditions studied

- Barrett's Esophagus With or Without Dysplasia
- Barrett Esophagus Adenocarcinoma

## Interventions

- **DRUG:** WGA-800CW

## Key facts

- **NCT ID:** NCT07643727
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643727, "Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*